FDA’s Schwartz Says New Draft Cybersecurity Guidance Addresses Emerging Threats
Agency shifts focus to software, removes tiered risk assessments
Suzanne Schwartz, director of the US FDA’s Office of Strategic Partnerships and Technology Innovation, tells Medtech Insight that recent cyberattacks have crippled hospitals networks, putting many patients at risk.
